Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

8

Number of overlapping holdings

17.0%

% of CANC's 47 holdings also in PBE

28.6%

% of PBE's 28 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus PBE)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in PBE
Overlap
GILEAD SCIENCES INC 5.3% 5.1% 5.1%
REGENERON PHARMACEUTICALS 5.0% 4.9% 4.9%
INCYTE CORP 4.3% 4.7% 4.3%
ILLUMINA INC 4.2% 5.1% 4.2%
BLUEPRINT MEDICINES CORP. 4.6% 2.7% 2.7%

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to PBE
ASTRAZENECA PLC 5.6%
ARGENX SE ADR 4.6%
REVOLUTION MEDICINES, INC. 4.2%
CHUGAI PHARMACEUTICAL CO LTD 3.6%
DAIICHI SANKYO CO LTD 3.0%
GUARDANT HEALTH, INC. 2.6%
GENMAB A/S SPONSORED ADR 2.4%
SPRINGWORKS THERAPEUTICS, INC. 2.4%
MERCK & CO. INC. 2.4%
CRISPR THERAPEUTICS AG 2.3%
CANC Underweight Relative to PBE
NATERA INC -5.1%
UNITED THERAPEUTICS CORP -5.0%
BIOGEN IDEC INC -4.8%
AMGEN INC -3.2%
SAREPTA THERAPEUTICS INC -3.0%
VERACYTE INC -2.9%
ACADIA PHARMACEUTICALS INC -2.9%
BIOCRYST PHARMACEUTICALS INC -2.9%
BIO-TECHNE CORPORATION -2.8%
BIOMARIN PHARMACEUTICAL INC -2.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY